Type 1 Together: A Peer Mentorship Program to Bolster Use of CGM
NCT ID: NCT06203067
Last Updated: 2025-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
106 participants
INTERVENTIONAL
2024-04-19
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Families who participate will be assigned by chance to one of two groups. One group will continue to see their Endocrinology provider who can give recommendations on ways to use CGM.
The other group will be in our Type 1 Together program for 6 months. This will include:
1. Monthly meetings with a community health worker with expertise in type 1 diabetes self-management,
2. Access to CGM-specific educational resources hosted on a mobile app, and
3. Meeting at least monthly with a mentor family who will provide mentorship on using CGM consistently.
The main questions the study aims to answer are:
1. Do families like the Type 1 Together program?
2. Do more families in the Type 1 Together program have better attitudes towards CGM, use CGM more consistently, and have lower HbA1c?
3. Does the Type 1 Together program reduce racial and ethnic differences in attitudes towards CGM, consistent use of CGM, and HbA1c?
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 1 Together
In Type 1 Together, families will work with other families who have experience using CGM (Peer Mentors) to overcome common barriers to CGM use. Families in the Type 1 Together program will also have access to CGM-specific educational materials, a digital journal to facilitate patient-provider communication around issues with CGM, and social determinant of health screening and intervention with a diabetes community health worker.
Type 1 Together
In Type 1 Together, families will work with other families who have experience using CGM (Peer Mentors) to overcome common barriers to CGM use. Families in the Type 1 Together program will also have access to CGM-specific educational materials, a digital journal to facilitate patient-provider communication around issues with CGM, and social determinant of health screening and intervention with a diabetes community health worker.
Standard of Care
Quarterly clinic visits with endocrinology provider.
Standard of Care
Quarterly clinic visits with endocrinology provider.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard of Care
Quarterly clinic visits with endocrinology provider.
Type 1 Together
In Type 1 Together, families will work with other families who have experience using CGM (Peer Mentors) to overcome common barriers to CGM use. Families in the Type 1 Together program will also have access to CGM-specific educational materials, a digital journal to facilitate patient-provider communication around issues with CGM, and social determinant of health screening and intervention with a diabetes community health worker.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with type 1 diabetes for at least 6 months
* Does not use CGM OR uses CGM \< 24 out of the past 30 days
* Use CGM 24 to 30 of the past 30 days but most recent HbA1c was 9% or more
* Able to read and write in English
Exclusion Criteria
* Intellectual disability
* Severe psychiatric comorbidities
12 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of General Medical Sciences (NIGMS)
NIH
Nemours Children's Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paul Enlow
Research Scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nemours Children's Hospital, Delaware
Wilmington, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5438
Identifier Type: OTHER
Identifier Source: secondary_id
1990806
Identifier Type: -
Identifier Source: org_study_id